Alliancebernstein L.P. Mei Pharma, Inc. Transaction History

Alliancebernstein L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.42 - $0.65 $9,954 - $15,405	-23,700 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.54 - $2.74 $26,136 - $132,616	-48,400 Reduced 67.13%	23,700 $14,000
Q3 2021 Nov 10, 2021	SELL	$2.52 - $2.99 $13,860 - $16,445	-5,500 Reduced 7.09%	72,100 $199,000
Q2 2021 Jul 30, 2021	BUY	$2.6 - $3.65 $23,920 - $33,580	9,200 Added 13.45%	77,600 $221,000
Q4 2020 Feb 08, 2021	SELL	$2.6 - $3.32 $13,780 - $17,596	-5,300 Reduced 7.19%	68,400 $181,000
Q3 2020 Nov 12, 2020	SELL	$2.46 - $4.27 $72,816 - $126,391	-29,600 Reduced 28.65%	73,700 $230,000
Q2 2020 Aug 13, 2020	BUY	$1.45 - $4.3 $116,725 - $346,150	80,500 Added 353.07%	103,300 $427,000
Q1 2020 May 14, 2020	BUY	$0.75 - $2.55 $17,100 - $58,139	22,800 New	22,800 $37,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $385M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.